These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Psychedelic treatment of functional neurological disorder: a systematic review. Butler M; Seynaeve M; Nicholson TR; Pick S; Kanaan RA; Lees A; Young AH; Rucker J Ther Adv Psychopharmacol; 2020; 10():2045125320912125. PubMed ID: 32435447 [TBL] [Abstract][Full Text] [Related]
5. Opinion, knowledge, and clinical experience with functional neurological disorders among Italian neurologists: results from an online survey. Tinazzi M; Fiorio M; Berardelli A; Bonetti B; Bonifati DM; Burlina A; Cagnin A; Calabria F; Corbetta M; Cortelli P; Giometto B; Guidoni SV; Lopiano L; Mancardi G; Marchioretto F; Pellegrini M; Teatini F; Tedeschi G; Tesolin L; Turinese E; Zappia M; Marotta A J Neurol; 2022 May; 269(5):2549-2559. PubMed ID: 34665330 [TBL] [Abstract][Full Text] [Related]
6. [Validated care programs for patients with functional neurological disorders]. Rauline G; Hingray C; Carle-Toulemonde G; Hubsch C; El Hage W; Conejero I; Samalin L; Garcin B; Gharib A Encephale; 2023 Aug; 49(4S):S33-S41. PubMed ID: 37400332 [TBL] [Abstract][Full Text] [Related]
7. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France. Batisse A; Leger S; Vicaut E; Gerbaud L; Djezzar S Public Health; 2021 May; 194():75-78. PubMed ID: 33865150 [TBL] [Abstract][Full Text] [Related]
8. Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches. Andersson M; Persson M; Kjellgren A Harm Reduct J; 2017 Sep; 14(1):60. PubMed ID: 28870224 [TBL] [Abstract][Full Text] [Related]
9. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Lucas P; Walsh Z; Crosby K; Callaway R; Belle-Isle L; Kay R; Capler R; Holtzman S Drug Alcohol Rev; 2016 May; 35(3):326-33. PubMed ID: 26364922 [TBL] [Abstract][Full Text] [Related]
10. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances. Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968 [TBL] [Abstract][Full Text] [Related]
11. Problematic khat use as a possible risk factor for harmful use of other psychoactive substances: a mixed method study in Ethiopia. Mihretu A; Teferra S; Fekadu A Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):47. PubMed ID: 29096691 [TBL] [Abstract][Full Text] [Related]
12. Toward a possible trauma subtype of functional neurological disorder: Impact on symptom severity and physical health. Paredes-Echeverri S; Guthrie AJ; Perez DL Front Psychiatry; 2022; 13():1040911. PubMed ID: 36458126 [TBL] [Abstract][Full Text] [Related]
13. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness. Gray R; Bressington D; Hughes E; Ivanecka A J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639 [TBL] [Abstract][Full Text] [Related]
15. Functional Neurological Disorders in the medical education: An urgent need to fill the gaps. de Liège A; Carle G; Hingray C; Lehn A; Autier L; Degos B; Garcin B Rev Neurol (Paris); 2022 Oct; 178(8):788-795. PubMed ID: 35863918 [TBL] [Abstract][Full Text] [Related]
16. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Palamar JJ; Martins SS; Su MK; Ompad DC Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051 [TBL] [Abstract][Full Text] [Related]
17. Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Nicholson TR; Carson A; Edwards MJ; Goldstein LH; Hallett M; Mildon B; Nielsen G; Nicholson C; Perez DL; Pick S; Stone J; ; J Neuropsychiatry Clin Neurosci; 2020; 32(1):33-42. PubMed ID: 31865871 [TBL] [Abstract][Full Text] [Related]